IL165780A0 - Method for preparing solid dosage form of desmopressin - Google Patents

Method for preparing solid dosage form of desmopressin

Info

Publication number
IL165780A0
IL165780A0 IL16578004A IL16578004A IL165780A0 IL 165780 A0 IL165780 A0 IL 165780A0 IL 16578004 A IL16578004 A IL 16578004A IL 16578004 A IL16578004 A IL 16578004A IL 165780 A0 IL165780 A0 IL 165780A0
Authority
IL
Israel
Prior art keywords
desmopressin
dosage form
solid dosage
preparing solid
preparing
Prior art date
Application number
IL16578004A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL165780(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL165780A0 publication Critical patent/IL165780A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL16578004A 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin IL165780A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin

Publications (1)

Publication Number Publication Date
IL165780A0 true IL165780A0 (en) 2006-01-15

Family

ID=34560171

Family Applications (3)

Application Number Title Priority Date Filing Date
IL189107A IL189107A0 (en) 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin
IL202881A IL202881A0 (en) 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin
IL16578004A IL165780A0 (en) 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL189107A IL189107A0 (en) 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin
IL202881A IL202881A0 (en) 2003-12-29 2004-12-15 Method for preparing solid dosage form of desmopressin

Country Status (12)

Country Link
EP (1) EP1550439B1 (xx)
AR (1) AR047155A1 (xx)
AT (1) ATE319430T1 (xx)
DE (1) DE60303872T2 (xx)
DK (1) DK1550439T3 (xx)
ES (1) ES2254858T3 (xx)
HK (1) HK1079696A1 (xx)
IL (3) IL189107A0 (xx)
NO (1) NO20045657L (xx)
PT (1) PT1550439E (xx)
SI (1) SI1550439T1 (xx)
TW (1) TWI282284B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
LT3225250T (lt) 2008-05-21 2019-11-11 Ferring Bv Burnoje disperguojamas desmopresinas, skirtas nikturijos nepertraukiamo miego pirminio periodo pailginimui

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
KR20040047915A (ko) * 2001-10-15 2004-06-05 룀 게엠베하 운트 콤파니 카게 활성제로서 펩타이드 또는 단백질을 함유하는 생약 형태를제조하기 위한 공중합체의 용도
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin

Also Published As

Publication number Publication date
TW200528141A (en) 2005-09-01
AR047155A1 (es) 2006-01-11
NO20045657D0 (no) 2004-12-27
ES2254858T3 (es) 2006-06-16
EP1550439B1 (en) 2006-03-08
HK1079696A1 (en) 2006-04-13
PT1550439E (pt) 2006-06-30
ATE319430T1 (de) 2006-03-15
SI1550439T1 (sl) 2006-08-31
NO20045657L (no) 2005-06-30
DK1550439T3 (da) 2006-04-03
EP1550439A1 (en) 2005-07-06
IL189107A0 (en) 2008-06-05
IL202881A0 (en) 2011-07-31
DE60303872D1 (de) 2006-05-04
TWI282284B (en) 2007-06-11
DE60303872T2 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
HK1085480A1 (en) Process for the preparation of roflumilast
HRP20150163T1 (xx) Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
SG137677A1 (en) Improved process for preparing polyalkenylsuccinimides
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
IL171789A (en) Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
HK1079696A1 (en) Method for preparing a solid dosage form of desmopressin
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
EP1556400A4 (en) PROCESS FOR THE PREPARATION OF 2-HALOGEN-2-DESOXYADENOSINE COMPOUNDS FROM 2-DESOXYGUANOSINE
PL377822A1 (pl) Sposób sporządzania octanu metylo-2-difenylometylosulfinylu
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
AU2003256006A8 (en) Improved process for preparation of risperidone
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
IL155234A0 (en) Process for the preparation of cyclic diketones
HUP0401379A2 (en) Process for the preparation of risperidon
IL164788A0 (en) Process for the preparation of 3-isochromanone
ZA200603113B (en) Process for the preparation of risperidone
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
PL381356A1 (pl) Sposób wytwarzania stałej postaci dawkowanej
HUP0300255A3 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
GB2412373B (en) Process for preparing guggulsterones
SI1673365T1 (sl) Postopek za pripravo Z-flupentiksola.